Cite
Kong X, Hellermann GR, Zhang W, et al. Chitosan Interferon-gamma Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses. Allergy Asthma Clin Immunol. 2008;4(3):95-105doi: 10.1186/1710-1492-4-3-95.
Kong, X., Hellermann, G. R., Zhang, W., Jena, P., Kumar, M., Behera, A., Behera, S., Lockey, R., & Mohapatra, S. S. (2008). Chitosan Interferon-gamma Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 4(3), 95-105. https://doi.org/10.1186/1710-1492-4-3-95
Kong, Xiaoyuan, et al. "Chitosan Interferon-gamma Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 4,3 (2008): 95-105. doi: https://doi.org/10.1186/1710-1492-4-3-95
Kong X, Hellermann GR, Zhang W, Jena P, Kumar M, Behera A, Behera S, Lockey R, Mohapatra SS. Chitosan Interferon-gamma Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses. Allergy Asthma Clin Immunol. 2008 Sep 15;4(3):95-105. doi: 10.1186/1710-1492-4-3-95. Epub 2008 Sep 15. PMID: 20525130; PMCID: PMC2868869.
Copy
Download .nbib